Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Directed differentiation of motor neuron cell-like cells from human adipose-derived stem cells in vitro.

Liqing Y., Jia G., Jiqing C., Ran G., Fei C., Jie K.

Laboratory Study on Back & Spine, published in Neuroreport (2011) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Neuroreport (2011)
Country
England
Reported sample size
—
Source database
PubMed
PMID
21532392
DOI
10.1097/WNR.0b013e3283469615
Citations
36

Abstract (original English)

The capacity of human adipose-derived stem cells (hADSCs) to differentiate into motor neurons and the identity of molecular factors that confer hADSCs with the competence of motor neurons have yet to be elucidated. Here, retinoic acid and sonic hedgehog were applied to examine whether hADSCs could be differentiated into motor neurons. As early as 6 h after induction, hADSCs were changed toward neuronal morphology. After induction, hADSCs showed positive immunocytochemical staining for β-III-tubulin, choline acetyltransferase, and neuron-specific enolase. Reverse-transcriptase polymerase chain reaction characterization indicated that cells differentiated from hADSCs were restricted to the ventral spinal fate (Nkx2.2, Pax6, Hb9, and Olig2). Our results suggest that hADSCs may be a potential candidate in cellular therapy for motor neuron disease.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAdult Stem CellsCell DifferentiationHomeobox Protein Nkx-2.2Homeodomain ProteinsHumansImmunohistochemistryIn Vitro TechniquesIntercellular Signaling Peptides and ProteinsMotor Neurons

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research